In this session hosted by Sepsis Alliance and sponsored by Inflammatix, join Tim Sweeney, MD, PhD, CEO of Inflammatix to learn how the immune response to infections can be leveraged to develop advanced diagnostics for the point of care (POC) setting to improve sepsis outcomes in clinical practice.
Tim Sweeney, MD, PhD (Co-Founder and CEO, Inflammatix, Inc)
